SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-003028
Filing Date
2018-02-23
Accepted
2018-02-23 16:01:11
Documents
4
Period of Report
2018-02-23
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rare-8k_20180223.htm 8-K 29236
2 EX-99.1 rare-ex991_6.htm EX-99.1 26681
3 GRAPHIC g2018022222461756812146.jpg GRAPHIC 102711
4 GRAPHIC g2018022222461756612146.jpg GRAPHIC 22876
  Complete submission text file 0001564590-18-003028.txt   214264
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36276 | Film No.: 18636520
SIC: 2834 Pharmaceutical Preparations